The microbiological and clinical outcome of guide wire exchanged versus newly inserted antimicrobial surface treated central venous catheters.
Crit Care. 2013 Sep 3;17(5):R184
Authors: Parbat N, Sherry N, Bellomo R, Schneider AG, Glassford NJ, Johnson PD, Bailey M
INTRODUCTION: The management of suspected central venous catheter (CVC)-related sepsis by guide wire exchange (GWX) is not recommended. However, GWX for new antimicrobial surface treated (AST) triple lumen CVC's has never been studied. We aimed to compare the microbiological outcome of triple lumen AST CVC's inserted by GWX (GWX-CVC's) with newly inserted triple lumen AST CVC's (NI-CVC's).
METHODS: We studied a cohort of 145 consecutive patients with GWX-CVC's and contemporaneous site-matched control cohort of 163 patients with a NI-CVC's in a tertiary intensive care unit (ICU).
RESULTS: GWX-CVC and NI-CVC patients were similar for mean age (58.7 vs. 62.2 years), gender (88 (60.7%) vs. 98 (60.5%) male) and illness severity on admission (mean APACHE III: 71.3 vs. 72.2). However, GWX patients had longer median ICU length of stay (12.2 vs. 4.4 days; P<0.001) and median hospital length of stay (30.7 vs. 18.0 days; P <0.001). There was no significant difference with regard to the number of CVC tips with bacterial or fungal pathogen colonization among GWX-CVC's vs. NI-CVC's [5 (2.5%) vs. 6 (7.4%); P = 0.90]. Catheter-associated blood stream infection (CA-BSI) occurred in 2 (1.4%) GWX patients compared with 3 (1.8%) NI-CVC patients (p=0.75). There was no significant difference in hospital mortality [35 (24.1%) vs. 48 (29.4%); P= 0.29].
CONCLUSIONS: GWX-CVC's and NI-CVC's had similar rates of tip colonization at removal, CA-BSI and mortality. If the CVC removed by GWX is colonized, a new CVC must then be inserted at another site. In selected ICU patients at higher central vein puncture risk receiving AST CVC's GWX may be an acceptable initial approach to line insertion.
PMID: 24004883 [PubMed - as supplied by publisher]